Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1986-07-28
1989-03-28
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
A61K 3318
Patent
active
048162558
ABSTRACT:
This invention relates to a composition for use in the treatment of fibrocystic dysplasia which may reduce or dissipate cyst formation in the female breast and alleviate the pain and discomfort associated with this disease. More particularly, this invention relates to a composition for the treatment of fibrocystic dysplasia which is comprised of a solution of elemental iodine (I.sub.2). For the purposes of this application, elemental iodine refers to diatomic iodine (I.sub.2) which may also be referred to as metallic iodine or iodine metal. The elemental iodine is soluble in water, that leaves it thermodynamically free. The term "aqueous iodine" may also be used to refer to such an aqueous solution.
REFERENCES:
patent: 2816854 (1957-12-01), Gross
patent: 4187294 (1980-02-01), Ishikawa et al.
patent: 4259322 (1981-03-01), Lim
patent: 4338304 (1982-07-01), Kamimae et al.
patent: 4384960 (1983-05-01), Polley
patent: 4394376 (1983-07-01), Kamimae et al.
patent: 4555347 (1985-11-01), O'Dowd et al.
Chem. Abst. 75:17655p (1971)--Eskin.
Chem. Abst. 84:126,316k (1976)--Stringer et al.
Chem. Abst. 90:135,752a (1979)--Eskin.
Chem. Abst. 94:41160m (1981)--Bloomer et al.
Chem. Abst. 99:136,212x (1983)--Bloomer et al.
Chem. Abst. 101:126,735r (1984)--Song et al.
Eskin B. A.--Iodine Metabolism and Breast Cancer, Transactions of the New York Academy of Science, 1970, 32(8), 911-47, See also Chem. Abstracts, at 75: 17655p (1971).
Moss et al., Invest. Radiol. 7, 335 (Jul.-Aug. 1972).
Zak et al., J. Am. Pharm. Ass. Sci. 41, 260 (1952).
Eskin et al., Int. J. Gyn-Obs. 8, 232 (1970).
U.S. Pharmacopea XVIII, p. 733 (1970).
Banfield et al., J. Am. Can. Inst. 46, 269 (1971).
Hetzel, D. S.--Iodine Deficiency Disorders (I.D.D.) and their Eradication, Lancet 12, Nov. 1983, pp. 1126-1129.
Eskin, B. A.--Iodine and Breast Cancer-A 1982 Update, Biological Trace Element Research 5, 1983, pp. 399-412.
Honour, A. J., N. B. Bryant et al--Secretion of Radio Iodine in Digestive Juices and Milk in Man, Clinical Science 11, 1952; pp. 447-462.
Beatson, G. T.--On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment with Illustrative Cases, Lancet 2, 1896, pp. 162-165.
Kelly, F. C. and Snedden, W. W.--Prevalence and Geographical Distribution of Indemic Goitre, W.H.O. Monograph, 44; pp. 27-233.
Eskin, B. A.--Iodine Metabolism and Breast Cancer--Transactions of the New York Academy of Sciences, Series II, vol. 32, 1970; pp. 911-947.
Vishnyakova, V. V. et al--On the Treatment of Dyshormonal Hyperplasia of Mammary Glands, Vestin. Akad. Med. Mauk. S.S.S.R. 21:19, 1966.
Roberts, M. M. et al.--Risk of Breast Cancer in Women with History of Benign Disease of the Breast--British Medical Journal, Jan. 28, 1984, vol. 288; pp. 275-278.
Peacock, Jr., Erlee--Management of Benign Disease of the Breast--American Surgeon, 1978, vol. 44(10): pp. 626-630.
Haagensen, C. D.--Disease of the Breast, Second Edition, W. B. Saunders 1971; pp. 380-383.
Gairard, B., et al--Proteins and Ionic Components in the Breast Cyst Fluid, Endocrinology of Cystic Breast Disease, Raven Press, 1983, pp. 191-195.
Gros, Ch., et al--Classification Thermographique des Cancers Mammaires--Bull Cancer (Paris) 58; pp. 351-362, 1971.
Spratt, J. S. et al--Association of Chronic Cystic Mastopathy, Xeromammographic Patterns and Cancer (prepublication).
Cole, E. N., et al--Is Prolactin a Fluid and Electrolyte Regulating Hormone in Man, J. Physiology, 1975, 252.
Cole, E. N., R. A. Gillwood et al--Serum Prolactin Concentrations in Benign Breast Disease Throughout the Menstrual Cycle, Europ. J. Cancer, vol. 13, pp. 597-603.
Minton, J. P., et al--Caffeine, Cyclic Nucleotides and Breast Disease, Surgery 1979, 86:105-109.
Fratkin, L. B.--The Hyperestrogen State, Paper presented at the North Pacific Surgery Meeting, Tacoma, Washington, 1980. (unpublished).
Moosa, A. R. et al--Thyroid Status and Breast Cancer--Royal College of Surgeons, England 53, 1973.
Greenblatt, R. B. et al--Danazol in the Treatment of Mammary Dysplasia, Fertility and Sterility 34, 1980. pp. 242-245.
Eskin, B. A. et al--Human Breast Uptake of Radioactive Iodine, Obstetrics and Gynecology vol. 44, No. 3, Sep. 1985, pp. 398-402.
Eskin, B. A.--Thyroid Hormones and Tumor Development--Chapter 6, Influences of Hormones in Tumor Development, pp. 129-156.
Riggs, D. S. et al--Investigations on the Nature of Blood Iodine.
Yunbing, G. et al--Clinical Observation of 174 Cases of Hyperplastic Cystic Disease of Breast Treated with Traditional Chinese Medicine, Journal of Traditional Chinese Medicine 3(4), 1983; pp. 291-294.
Amalric, R. et al--Dysplasies Fibro-Kystiques Aspects Thermographiques et Radiographiques, Senologia 2: 1977, 45-51.
Eskin Bernard A.
Ghent William R.
LandOfFree
Treatment of iodine deficiency breast syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of iodine deficiency breast syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of iodine deficiency breast syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1658072